| Active Market | Forge Price1 | Last Funding Round | Trade Eligibility | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Company | Sector & Subsector | Market Activity4   |
Highest Bid | Lowest Ask | Last Matched | +/- to LFR | $ Total Bids | $ Total Asks | # Bids | # Asks | Current Price |
6-month |
1-year |
Total Funding |
Round | Date | Amount Raised |
Post-Money Valuation3 |
Price |
Key Investors | Common | Preferred | Fund | ||
 | Boxed | Consumer & Lifestyle E-commerce | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $339.14MM | Series E-1 | 6/30/2020 | $30.9MM | $477.46MM | $7.09 | Undisclosed investors | ||||
 | Matterport | Industrial Augmented / Virtual Reality | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $144.15MM | Series D | 4/29/2020 | $86.21MM | $439.01MM | $8.31 | Lux Capital, DCM Ventures, Qualcomm Ventures, Rev1 Ventures, Prairie Management Group, Plug and Play Tech Center, CBRE Group, BoxGroup, iRobot Ventures | ||||
 | Latch | Consumer & Lifestyle Consumer Electronics | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $161.83MM | Series B-1 | 8/1/2019 | $67.81MM | $407.38MM | $3.74 | Avenir, Brookfield Ventures, Lux Capital, RRE, RxR Realty, Tishman Speyer, Third Prime, Camber Creek, Primary Venture Partners | ||||
 | Fast Radius | Industrial Manufacturing | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $61.21MM | Series B | 4/2/2019 | $48.02MM | $392.68MM | $13.49 | Drive Capital, Hyde Park Venture Partners, Jump Capital, SkyDeck, UPS Strategic Enterprise Fund | ||||
 | TriSalus Life Sciences | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $198.81MM | Series B-2 | 10/5/2022 | $15.32MM | $375.88MM | $0.35 | Undisclosed Investors | ||||
 | Spire | Enterprise Software Data Intelligence | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $157.76MM | Series C | 11/15/2017 | $69.47MM | $363.5MM | $8.71 | Luxembourg Future Fund, Seraphim Space, Expon Capital, Lemnos Labs, Industry Ventures, Empiricus Capital | ||||
 | Porch | Real Estate Real Estate Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $122.34MM | Series C | 1/7/2020 | $20.62MM | $350.67MM | $3.50 | Undisclosed Investors | ||||
 | ARS Pharmaceuticals | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $76.55MM | Series D | 8/31/2021 | $55MM | $310.11MM | $5.89 | SR One, RA Capital Management, Deerfield | ||||
 | Tango Therapeutics | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $166.88MM | Series B-1 | 8/17/2020 | $51.18MM | $305.79MM | $1.89 | Casdin Capital, Boxer Capital, Cormorant Asset Management, Gilead Sciences | ||||
 | Korro Bio | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $593.6MM | Series B-2 | 1/5/2022 | $45.12MM | $290.4MM | $2.78 | Eventide Asset Management, Fidelity, Invus, Point72, Verition Fund Management, Monashee Investment Management, Sixty Degree Capital, Atlas Venture, NEA, Wu Capital, Qiming Venture Partners, Surveyor Capital, Cormorant Asset Management, MP Healthcare Venture Management, Alexandria Venture Investments | ||||
 | BarkBox | Consumer & Lifestyle Other Consumer & Lifestyle | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $67.36MM | Series C | 12/21/2016 | $37.32MM | $270.22MM | $17.42 | August Capital, Founders Circle Capital, Resolute Ventures, RRE Ventures | ||||
 | Disc Medicine | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $145MM | Series B | 9/2/2021 | $90MM | $253.72MM | $2.40 | OrbiMed, Arix Bioscience, Janus Henderson Investors, 5AM Ventures, Rock Springs Capital, Nantahala Capital Management, Willett Advisors, Alexandria Venture Investments, Novo Holdings A/S, Access Biotechnology, Atlas Venture | ||||
 | Neurogene | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $183.58MM | Series B | 12/16/2020 | $115MM | $248.92MM | $2.44 | EcoR1 Capital, Samsara BioCapital, EcorR1 Capital, Cormorant Asset Management, Redmile Group | ||||
 | ionQ | Technology Hardware Computing Hardware | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $96.18MM | Series B-1 | 10/22/2019 | $73.7MM | $212.64MM | $5.58 | Samsung Catalyst Fund, Mubadala Capital | ||||
 | eFFECTOR Therapeutics | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $152.08MM | Series C | 8/24/2017 | $39.1MM | $197.73MM | $0.51 | Pfizer Venture Investments, Alexandria Venture Investments, U.S. Venture Partners, Abingworth, Novartis Venture Fund, SR One, The Column Group, Altitude Life Science Ventures, Sectoral Asset Management, Abbvie Biotech Ventures, BioMed Ventures, Astellas Ventures | ||||
 | Rigetti Computing | Technology Hardware Computing Hardware | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $71.04MM | Series C | 2/18/2020 | $44.29MM | $162.23MM | $0.91 | Undisclosed Investors | ||||
 | Momentus Space | Industrial Aerospace & Defense | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $36.96MM | Series A | 7/16/2019 | $18.88MM | $90.23MM | $0.29 | Prime Movers Lab, Y Combinator, The Lerner Family, The University of Wyoming Foundation, Quiet Capital, Montain Nazca, ACE & Co., Liquid 2 Ventures, Drake Management | ||||
 | Molekule | Consumer & Lifestyle Consumer Electronics | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $282.47MM | Series 1 | 5/19/2022 | $22.2MM | $59.77MM | $0.39 | Undisclosed Investors | ||||